Award

Cowman regarded as 'a world leader in malaria research'

He won the ASBMB's 2015 Alice and C.C. Wang Award in Molecular Parasitology
Maggie Kuo
March 01, 2015

Alan F. Cowman, professor and head of the Division of Infection and Immunity at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, is the recipient of the 2015 American Society for Biochemistry and Molecular Biology’s Alice and C.C. Wang Award in Molecular Parasitology.

Cowman_Alan-web.jpg "It is a great honor to receive the Alice and C.C. Wang award, and I thank Alice and C.C. for their continued support of parasitology research. This award recognizes the many talented graduate students and postdocs who have been so pivotal to the work done by the lab over the years. I would like to thank them and the many collaborators with whom I have worked. " — ALAN F. COWMAN

The award is given to researchers who have made significant contributions to the field of molecular parasitology. Recipients of this award are internationally recognized scientific leaders who have made important discoveries in the field and continue to lead the forefront of research in the area. Cowman was awarded for his work on understanding Plasmodium falciparum, the protozoan parasite that causes the most severe form of malaria in humans.

“Professor Alan Cowman has made a number of profoundly important discoveries over the past 25 years of his research career in malaria that see him recognized as one of the very top, possibly the actual top, in the field internationally,” Brendan Crabb of the Burnet Institute wrote in his letter of support for Cowman’s nomination.

Malaria is a mosquito-borne infectious disease that is a major cause of illness in approximately 100 countries. More than 300 million people are infected by the parasite, and up to 800,000, mostly children, die every year.

From the start of his career, the findings and technologies produced from Cowman’s laboratory have been revolutionary for the field of malaria biology. His early work identified mutations in P. falciparum genes that conferred resistance to anti-malarial drug compounds. “The work provided an understanding of the evolution of resistance to those compounds and, as a direct result, provided the information to allow the study of the geographical spread and emergence of drug resistant P. falciparum in endemic areas, giving rise to a new field of molecular epidemiology,” Doug Hilton of the Walter and Eliza Hall Institute of Medical Research wrote in his nomination letter.

Cowman’s laboratory was the first to create a genetic knockout in P. falciparum by genetically manipulating its genome. The feat was followed by the first large-scale knockout screen in malaria biology. The screen identified important proteins key to the parasite’s survival in the host. “This was a significant leap in the field, and the genetic technology he created is now used in every malaria research laboratory in the world,” Hilton continued.

The impact of Cowman’s work expands beyond the scientific community into the realm of public health. The tools developed during his early work to monitor molecular markers of drug resistance have been used to determine which drugs would be most effective in patients in specific endemic areas. Using the genetic technology he had developed, Cowman and his laboratory collaborated with Stefan Kappe at the Seattle Biomedical Research Institute to create the first genetically engineered live attenuated malaria vaccine. The vaccine has completed Phase 1 clinical trials, which were funded by the Bill and Melinda Gates Foundation and the Grand Challenges Foundation.

The quality of his work is reflected in his extensive publication record, with many in the “world’s most prestigious scientific journals, where they belong,” B. Brett Finlay of the University of British Columbia wrote in his letter of support. This award will add to a long list of honors already bestowed upon Cowman, including induction as a Howard Hughes Medical Institute International Scholar, a fellow of the Australian Academy of Science and a fellow of the Royal Society.

“Working in a highly competitive field, on an organism that is notoriously difficult to manipulate, his laboratory relentlessly makes significant leaps in our understanding of malaria pathogenesis,” Finlay wrote. “These breakthroughs have changed people’s lives and health outcomes – something very few researchers can ever hope to claim in their lifetime.”

Cowman received his Ph.D. from the Walter and Eliza Hall Institute of Medical Research. After a postdoctoral fellowship at the University of California, Berkeley, Cowman returned to the institute and has been there since.

Cowman will receive his award during the 2015 Experimental Biology conference in Boston, where he will deliver his award lecture. The presentation will take place at 9:45 a.m. March 30 in the Boston Convention and Exhibition Center, Room 253 A.

Maggie Kuo

Maggie Kuo was an intern at ASBMB Today when she wrote this story. Today she is a writer at the American Physiological Society. She earned her Ph.D. in biomedical engineering at Johns Hopkins University.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Glycobiology society honors; NAI inducts Batzer; inspiring Latinx scientists
Member News

Glycobiology society honors; NAI inducts Batzer; inspiring Latinx scientists

September 28, 2020

Honors, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

Herbert Tabor 1918 – 2020
Retrospective

Herbert Tabor 1918 – 2020

September 24, 2020

F. Peter Guengerich remembers the contributions of the longtime editor of the Journal of Biological Chemistry who died in August.

ASBMB welcomes new members
Member News

ASBMB welcomes new members

September 21, 2020

The American Society for Biochemistry and Molecular biology welcomed more than 60 new members in April.

It all comes down to where we place our bets
Interview

It all comes down to where we place our bets

September 18, 2020

Mark Harpel works in a research unit at GlaxoSmithKline that helps choose the most promising targets for new drug development.

Understanding the impact of Type 1 diabetes susceptibility genes
Research Spotlight

Understanding the impact of Type 1 diabetes susceptibility genes

September 17, 2020

Starting in eighth grade, a series of mentors who saw something special in Sharifa Love–Rutledge helped her stay on the path to being a researcher — and becoming a mentor to others.

Cell biology, microbiology societies present awards
Member News

Cell biology, microbiology societies present awards

September 14, 2020

Honorees include ASBMB members Joann Trejo, James Olzmann, Steven Farber, Sue Wickner and Bernard Moss.